NO20034190L - Topoisomerase I-selektive cytotoksiske sukkerderivater av indolopyrrolokarbazoler - Google Patents

Topoisomerase I-selektive cytotoksiske sukkerderivater av indolopyrrolokarbazoler

Info

Publication number
NO20034190L
NO20034190L NO20034190A NO20034190A NO20034190L NO 20034190 L NO20034190 L NO 20034190L NO 20034190 A NO20034190 A NO 20034190A NO 20034190 A NO20034190 A NO 20034190A NO 20034190 L NO20034190 L NO 20034190L
Authority
NO
Norway
Prior art keywords
indolopyrrolocarbazoles
topoisomerase
sugar derivatives
selective cytotoxic
cytotoxic
Prior art date
Application number
NO20034190A
Other languages
English (en)
Other versions
NO20034190D0 (no
Inventor
Edward H Ruediger
Mark George Saulnier
Francis Beaulieu
Carol Bachand
Neelakantan Balusubramanian
Byron Hepler Long
David Bertil Frennesson
Kurt Zimmerman
Narasimhulu B Naidu
Karen M Stoffan
Denis Robert St Laurent
Richard Christopher Oglesby
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20034190D0 publication Critical patent/NO20034190D0/no
Publication of NO20034190L publication Critical patent/NO20034190L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20034190A 2001-03-22 2003-09-19 Topoisomerase I-selektive cytotoksiske sukkerderivater av indolopyrrolokarbazoler NO20034190L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27804301P 2001-03-22 2001-03-22
PCT/US2002/008819 WO2002077255A1 (en) 2001-03-22 2002-03-22 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles

Publications (2)

Publication Number Publication Date
NO20034190D0 NO20034190D0 (no) 2003-09-19
NO20034190L true NO20034190L (no) 2003-11-19

Family

ID=23063451

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034190A NO20034190L (no) 2001-03-22 2003-09-19 Topoisomerase I-selektive cytotoksiske sukkerderivater av indolopyrrolokarbazoler

Country Status (22)

Country Link
US (1) US6855698B2 (no)
EP (1) EP1370673A4 (no)
JP (1) JP2004534006A (no)
KR (1) KR20030085035A (no)
CN (1) CN1509335A (no)
BG (1) BG108183A (no)
BR (1) BR0208322A (no)
CA (1) CA2441412A1 (no)
CZ (1) CZ20032876A3 (no)
EE (1) EE200300456A (no)
HR (1) HRP20030761A2 (no)
HU (1) HUP0400265A2 (no)
IL (1) IL157909A0 (no)
IS (1) IS6958A (no)
MX (1) MXPA03008589A (no)
NO (1) NO20034190L (no)
PL (1) PL368942A1 (no)
RU (1) RU2003131269A (no)
SK (1) SK12022003A3 (no)
WO (1) WO2002077255A1 (no)
YU (1) YU74103A (no)
ZA (1) ZA200307317B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4552842A (en) 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4567143A (en) * 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4785085A (en) 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
WO1989007105A1 (en) 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
DE3803620A1 (de) 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE3924538A1 (de) 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung
US5618809A (en) 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
IL97233A (en) 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them
US5478813A (en) 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
US5589365A (en) 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
NZ245203A (en) 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5668271A (en) 1991-11-29 1997-09-16 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
EP0630898B1 (en) * 1992-09-21 2001-11-28 Kyowa Hakko Kogyo Co., Ltd. Thrombocytopenia remedy
FR2696465B1 (fr) 1992-10-02 1994-12-23 Adir Nouveaux dérivés d'ellipticine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
JP3603322B2 (ja) 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
US5468872A (en) 1993-09-16 1995-11-21 Cephalon, Inc. K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders
WO1995030682A1 (fr) 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Derive d'indolopyrolocarbazole antitumoral
AU3086495A (en) 1994-08-02 1996-03-04 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazoles
US5475110A (en) 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles
US5705511A (en) 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
AU6888196A (en) * 1995-08-11 1997-03-12 Yale University Glycosylated indolocarbazole synthesis
IL127918A0 (en) * 1996-08-22 1999-11-30 Bristol Myers Squibb Co Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
CO4940430A1 (es) 1997-07-07 2000-07-24 Novartis Ag Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales
FR2801054B1 (fr) 1999-11-17 2003-06-13 Adir Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CN1509335A (zh) 2004-06-30
BR0208322A (pt) 2004-10-13
MXPA03008589A (es) 2003-12-08
YU74103A (sh) 2006-05-25
BG108183A (en) 2004-07-30
EP1370673A4 (en) 2006-08-09
US6855698B2 (en) 2005-02-15
EE200300456A (et) 2004-02-16
PL368942A1 (en) 2005-04-04
CA2441412A1 (en) 2002-10-03
IS6958A (is) 2003-09-16
RU2003131269A (ru) 2005-05-10
WO2002077255A1 (en) 2002-10-03
NO20034190D0 (no) 2003-09-19
KR20030085035A (ko) 2003-11-01
EP1370673A1 (en) 2003-12-17
IL157909A0 (en) 2004-03-28
US20030083271A1 (en) 2003-05-01
HRP20030761A2 (en) 2004-04-30
JP2004534006A (ja) 2004-11-11
SK12022003A3 (sk) 2004-05-04
HUP0400265A2 (hu) 2004-08-30
ZA200307317B (en) 2004-12-20
CZ20032876A3 (en) 2004-03-17

Similar Documents

Publication Publication Date Title
NO20030134D0 (no) Fremstilling av olefinderivater
PT1406628E (pt) Derivados de tera-hidroquinolina
NO20034523L (no) Pyrazolderivater for behandling av HIV
NO20013945D0 (no) Fremstilling av isoflavonderivater
AR028567A1 (es) Nuevos derivados de fenil-propargileter
IS7939A (is) Pýrasólpýridín afleiður
PT1343786E (pt) Novos derivados de pirazolopiridina substituidos por piridina
EE200100393A (et) Vähivastaste vahenditena kasulikud asendatud bitsüklilised derivaadid
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
AR028596A1 (es) Nuevos derivados de fenilglicina
DK1218382T3 (da) Bicykliske imidazo-3-ylaminderivater
DK1412328T3 (da) Dolastatin-10-derivater
DE50015443D1 (de) Bicyclische imidazo-5-yl-aminderivate
NO20023770D0 (no) Indol-3-ylderivater
EP1643987A4 (en) PODOPHYLLOTOXIN DERIVATIVES
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
ITMI991483A0 (it) Derivati tassanici e procedimenti per la loro preparazione
NO20024707D0 (no) Fremstilling av diacetaler av glyoksal
IL161560A0 (en) Anthelmintic compositions containing milbemycin derivatives
NO20034190D0 (no) Topoisomerase I-selektive cytotoksiske sukkerderivater av indolopyrrolokarbazoler
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
DE60200407D1 (de) Methylendioxy- Derivate
DK1385512T3 (da) Anvendelse af pyridoindolonderivater til fremstilling af anticancerlægemidler
DE60202381D1 (de) Paroxetin-n-formyl-derivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application